[Antisynthetase syndromes]
- PMID: 31346706
- DOI: 10.1007/s00393-019-0665-0
[Antisynthetase syndromes]
Abstract
Antisynthetase syndromes (ASS) are rare autoimmune diseases. Characteristic is the presence of at least one of the three main symptoms myositis, interstitial lung disease (ILD) and arthritis with possible accompanying symptoms, such as mechanic's hands and feet, Raynaud's disease and/or fever in combination with detection of an aminoacyl-tRNA synthetase antibody in peripheral blood. In addition to myositis, ILD is a frequent and often predominant organ involvement and is responsible for morbidity and mortality. Autoantibodies to 11 aminoacyl-tRNA synthetases are known of which 8 have so far been associated with the clinical manifestation of ASS. The Jo-1 antibody is by far the most frequent one. The antibodies differ in the rate and severity of the main and accompanying symptoms. Treatment with selected immunosuppressive medication depends on the extent and severity of organ involvement. With a 5-year survival rate of approximately 90%, the Jo-1 syndrome has the best prognosis.
Keywords: Antisynthetase antibodies; Interstitial lung disease; Jo-1; Mechanic’s hands; Polymyositis.
Similar articles
-
Myositis-related interstitial lung disease and antisynthetase syndrome.J Bras Pneumol. 2011 Jan-Feb;37(1):100-9. doi: 10.1590/s1806-37132011000100015. J Bras Pneumol. 2011. PMID: 21390438 Free PMC article. Review.
-
Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.J Dermatol. 2019 Oct;46(10):886-897. doi: 10.1111/1346-8138.15049. Epub 2019 Aug 16. J Dermatol. 2019. PMID: 31418479
-
Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.Immun Inflamm Dis. 2023 Nov;11(11):e1085. doi: 10.1002/iid3.1085. Immun Inflamm Dis. 2023. PMID: 38018600 Free PMC article.
-
Interstitial lung disease in a patient with antisynthetase syndrome and no myositis.Clin Rheumatol. 2007 Jan;26(1):108-11. doi: 10.1007/s10067-005-0111-3. Epub 2005 Nov 23. Clin Rheumatol. 2007. PMID: 16328094
-
Clinical manifestations and treatment of antisynthetase syndrome.Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101503. doi: 10.1016/j.berh.2020.101503. Epub 2020 Apr 11. Best Pract Res Clin Rheumatol. 2020. PMID: 32284267 Review.
Cited by
-
A 25-Year-Old Saudi Woman with a 2-Year History of Antisynthetase Syndrome with Interstitial Lung Disease Who Commenced Azathioprine Treatment in the Third Trimester of Pregnancy and Had a Successful Birth at Term.Am J Case Rep. 2022 Jul 7;23:e936833. doi: 10.12659/AJCR.936833. Am J Case Rep. 2022. PMID: 35794813 Free PMC article.
-
[Society for Pediatric and Adolescent Rheumatology (GKJR) diagnosis and treatment optimization board-New ways to the diagnosis and treatment of complex diseases : An analysis after 2 years testing in practice].Z Rheumatol. 2024 Feb;83(1):28-33. doi: 10.1007/s00393-023-01444-0. Epub 2023 Nov 10. Z Rheumatol. 2024. PMID: 37945990 German.
-
A distinct immune landscape in anti-synthetase syndrome profiled by a single-cell genomic study.Front Immunol. 2024 Oct 24;15:1436114. doi: 10.3389/fimmu.2024.1436114. eCollection 2024. Front Immunol. 2024. PMID: 39512337 Free PMC article.
-
Towards a Cure for HARS Disease.Genes (Basel). 2023 Jan 18;14(2):254. doi: 10.3390/genes14020254. Genes (Basel). 2023. PMID: 36833180 Free PMC article. Review.
-
An Observational Study on the Clinical Characteristics and Prognosis of Patients With Interstitial Lung Disease Secondary to Dermatomyositis and Antisynthetase Syndrome.Int J Rheumatol. 2024 Sep 26;2024:9679944. doi: 10.1155/2024/9679944. eCollection 2024. Int J Rheumatol. 2024. PMID: 39364301 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous